152 related articles for article (PubMed ID: 6457624)
1. A double blind study of prostacyclin in cardiopulmonary bypass surgery.
Walker ID; Davidson JF; Faichney A; Wheatley DJ; Davidson KG
Br J Haematol; 1981 Nov; 49(3):415-23. PubMed ID: 6457624
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin administration during cardiopulmonary bypass in man.
Longmore DB; Bennett JG; Hoyle PM; Smith MA; Gregory A; Osivand T; Jones WA
Lancet; 1981 Apr; 1(8224):800-4. PubMed ID: 6111672
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin in cardiopulmonary bypass operations.
Faichney A; Davidson KG; Wheatley DJ; Davidson JF; Walker ID
J Thorac Cardiovasc Surg; 1982 Oct; 84(4):601-8. PubMed ID: 6750247
[TBL] [Abstract][Full Text] [Related]
6. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
7. Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin.
Plachetka JR; Salomon NW; Larson DF; Copeland JG
Ann Thorac Surg; 1980 Jul; 30(1):58-63. PubMed ID: 6994666
[TBL] [Abstract][Full Text] [Related]
8. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization.
DiSesa VJ; Huval W; Lelcuk S; Jonas R; Maddi R; Lee-Son S; Shemin RJ; Collins JJ; Hechtman HB; Cohn LH
Ann Thorac Surg; 1984 Nov; 38(5):514-9. PubMed ID: 6388516
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass.
Aren C; Feddersen K; Rådegran K
Ann Thorac Surg; 1983 Jul; 36(1):49-54. PubMed ID: 6222712
[TBL] [Abstract][Full Text] [Related]
10. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
Addonizio VP; Fisher CA; Kappa JR; Ellison N
Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin inhibits 5-hydroxytryptamine release but stimulates thromboxane synthesis during cardiopulmonary bypass.
Aznavoorian SA; Utsunomiya T; Krausz MM; Cohn LH; Shepro D; Hechtman HB
Prostaglandins; 1983 Apr; 25(4):557-70. PubMed ID: 6348886
[TBL] [Abstract][Full Text] [Related]
12. Experience with prostacyclin in cardiopulmonary bypass in dog and man.
Longmore DB
Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):399-412. PubMed ID: 6117901
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
[TBL] [Abstract][Full Text] [Related]
14. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
15. Platelet proteins during and after prostacyclin therapy for lower limb ischaemia--suggestion of a rebound platelet activation.
Blättler W; Furrer K; Schriber K; Kofmehl R; Massini C
Vasa; 1981; 10(3):261-3. PubMed ID: 6169225
[No Abstract] [Full Text] [Related]
16. Prevention of acquired transient defect in platelet plug formation by infused prostacyclin.
Malpass TW; Hanson SR; Savage B; Hessel EA; Harker LA
Blood; 1981 Apr; 57(4):736-40. PubMed ID: 7008866
[TBL] [Abstract][Full Text] [Related]
17. Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery.
Nagaoka H; Innami R; Murayama F; Funakoshi N; Hirooka K; Watanabe M; Satoh M
J Cardiovasc Surg (Torino); 1991; 32(1):31-7. PubMed ID: 1707053
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostacyclin infusion on platelets and hemodynamics in coronary bypass surgery.
Arén C; Feddersen K; Rådegran K
Thorac Cardiovasc Surg; 1984 Apr; 32(2):81-4. PubMed ID: 6204413
[TBL] [Abstract][Full Text] [Related]
19. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
20. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass.
Haraldsson A; Kieler-Jensen N; Wadenvik H; Ricksten SE
Intensive Care Med; 2000 Feb; 26(2):188-94. PubMed ID: 10784307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
